Dipharma Group is a global CDMO and a leading manufacturer of Active Pharmaceutical Ingredients and Intermediates. As part of the global pharmaceutical industry, we serve human health and, therefore, operate to the highest standards of quality and safety with proven experience in handling complex and hazardous processes. Founded in 1949, Dipharma is a third-generation family-owned company with an outstanding history of stability, commitment, and financial soundness. Dipharma has now expanded into a global presence, with more than 550 skilled and highly committed employees, 4 cGMP plants, located in the U.S.A. and Italy, plus commercial offices in Italy, U.S.A. and China, serving over 200 customers in more than 60 countries. Our fully equipped R&D Centres, in the U.S.A. and Italy, develop innovative chemical processes and crystalline forms for leading pharmaceutical companies worldwide. Our manufacturing sites are equipped to supply quantities from laboratory to industrial scale, covering the entire lifecycle of a molecule. Full compliance with the highest GMP quality standard has been confirmed, since 1970, by an extensive list of successful inspections conducted by major Regulatory Agencies, such as the FDA, Italian Health Authorities and PMDA. Dipharma Group has the right size and variety of scale-up capabilities to act as a global player and manage processes efficiently, while offering flexibility and agility to promptly solve any challenge. Experience you can trust.